Do analysts prefer HKPD or COSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, HKPD or COSM?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $20.31M 0.20 -$30K N/A N/A Cosmos Health $65.27M 0.18 -$19.15M -$0.64 N/A

Do analysts rate HKPD or NHTC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Natural Health Trends 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, HKPD or NHTC?

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Natural Health Trends. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $20.31M 0.20 -$30K N/A N/A Natural Health Trends $39.78M 0.39 -$880K -$0.11 N/A

Do analysts recommend HKPD or EPSM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Epsium Enterprise 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, HKPD or EPSM?

Hong Kong Pharma Digital Technology has higher revenue and earnings than Epsium Enterprise. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $20.31M 0.20 -$30K N/A N/A Epsium Enterprise $5.12M 3.57 -$1.50M N/A N/A

Is HKPD or EPSM more profitable?

Company Net Margins Return on Equity Return on Assets Hong Kong Pharma Digital Technology N/A N/A N/A Epsium Enterprise N/A N/A N/A

Does the media prefer HKPD or EPSM?

In the previous week, Hong Kong Pharma Digital Technology and Hong Kong Pharma Digital Technology both had 2 articles in the media. Hong Kong Pharma Digital Technology's average media sentiment score of 1.31 beat Epsium Enterprise's score of 0.87 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hong Kong Pharma Digital Technology 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Epsium Enterprise 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer SCNX or HKPD?

Scienture currently has a consensus target price of $1.50, suggesting a potential upside of 306.17%. Given Scienture's stronger consensus rating and higher probable upside, analysts plainly believe Scienture is more favorable than Hong Kong Pharma Digital Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scienture 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, SCNX or HKPD?

Hong Kong Pharma Digital Technology has higher revenue and earnings than Scienture. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Scienture $430K 34.89 -$41.51M -$2.51 N/A Hong Kong Pharma Digital Technology $20.31M 0.20 -$30K N/A N/A

Is SCNX or HKPD more profitable?

Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Scienture's return on equity. Company Net Margins Return on Equity Return on Assets Scienture N/A -56.28% -44.76% Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts recommend HKPD or TLIH?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Ten-League International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, HKPD or TLIH?

Ten-League International has higher revenue and earnings than Hong Kong Pharma Digital Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hong Kong Pharma Digital Technology $20.31M 0.20 -$30K N/A N/A Ten-League International $59.24M 0.28 $4.34M N/A N/A

Is HKPD or TLIH more profitable?

Company Net Margins Return on Equity Return on Assets Hong Kong Pharma Digital Technology N/A N/A N/A Ten-League International N/A N/A N/A

Hong Kong Pharma Digital Technology (HKPD) Competitors

$0.37 +0.03 (+10.33%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$0.35 -0.02 (-4.98%)

As of 07/24/2026 06:09 PM Eastern

Compare

HKPD vs. COSM, NHTC, EPSM, SCNX, and TLIH

Should you buy Hong Kong Pharma Digital Technology stock or one of its competitors? MarketBeat compares Hong Kong Pharma Digital Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hong Kong Pharma Digital Technology include Cosmos Health (COSM), Natural Health Trends (NHTC), Epsium Enterprise (EPSM), Scienture (SCNX), and Ten-League International (TLIH). These companies are all part of the "wholesale" industry.

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Cosmos Health (NASDAQ:COSM) are both small-cap wholesale companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends and analyst recommendations.

In the previous week, Cosmos Health had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 3 mentions for Cosmos Health and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.31 beat Cosmos Health's score of 1.17 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hong Kong Pharma Digital Technology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cosmos Health	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hong Kong Pharma Digital Technology has a beta of 2.49, suggesting that its stock price is 149% more volatile than the broader market. Comparatively, Cosmos Health has a beta of 4.83, suggesting that its stock price is 383% more volatile than the broader market.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Cosmos Health's net margin of -30.41%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Cosmos Health	-30.41%	-52.85%	-17.87%

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Cosmos Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$20.31M	0.20	-$30K	N/A	N/A
Cosmos Health	$65.27M	0.18	-$19.15M	-$0.64	N/A

12.6% of Cosmos Health shares are owned by institutional investors. 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Hong Kong Pharma Digital Technology beats Cosmos Health on 6 of the 11 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Natural Health Trends?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Natural Health Trends (NASDAQ:NHTC) are both small-cap wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Hong Kong Pharma Digital Technology has higher earnings, but lower revenue than Natural Health Trends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$20.31M	0.20	-$30K	N/A	N/A
Natural Health Trends	$39.78M	0.39	-$880K	-$0.11	N/A

Hong Kong Pharma Digital Technology has a beta of 2.49, indicating that its stock price is 149% more volatile than the broader market. Comparatively, Natural Health Trends has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market.

In the previous week, Natural Health Trends had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 3 mentions for Natural Health Trends and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.31 beat Natural Health Trends' score of 0.30 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hong Kong Pharma Digital Technology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natural Health Trends	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Natural Health Trends	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Natural Health Trends' net margin of -3.03%. Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Natural Health Trends' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Natural Health Trends	-3.03%	-4.88%	-2.94%

10.1% of Natural Health Trends shares are owned by institutional investors. 12.9% of Natural Health Trends shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Hong Kong Pharma Digital Technology beats Natural Health Trends on 6 of the 11 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Epsium Enterprise?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Epsium Enterprise (NASDAQ:EPSM) are both small-cap wholesale companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Epsium Enterprise	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Epsium Enterprise	N/A	N/A	N/A

In the previous week, Hong Kong Pharma Digital Technology and Hong Kong Pharma Digital Technology both had 2 articles in the media. Hong Kong Pharma Digital Technology's average media sentiment score of 1.31 beat Epsium Enterprise's score of 0.87 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hong Kong Pharma Digital Technology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Epsium Enterprise	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hong Kong Pharma Digital Technology has higher revenue and earnings than Epsium Enterprise.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$20.31M	0.20	-$30K	N/A	N/A
Epsium Enterprise	$5.12M	3.57	-$1.50M	N/A	N/A

Hong Kong Pharma Digital Technology has a beta of 2.49, indicating that its share price is 149% more volatile than the broader market. Comparatively, Epsium Enterprise has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market.

Summary

Hong Kong Pharma Digital Technology beats Epsium Enterprise on 4 of the 5 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Scienture?

Scienture (NASDAQ:SCNX) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap wholesale companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

Hong Kong Pharma Digital Technology has higher revenue and earnings than Scienture.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scienture	$430K	34.89	-$41.51M	-$2.51	N/A
Hong Kong Pharma Digital Technology	$20.31M	0.20	-$30K	N/A	N/A

5.7% of Scienture shares are held by institutional investors. 21.4% of Scienture shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Hong Kong Pharma Digital Technology's return on equity of 0.00% beat Scienture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scienture	N/A	-56.28%	-44.76%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Scienture currently has a consensus target price of $1.50, suggesting a potential upside of 306.17%. Given Scienture's stronger consensus rating and higher probable upside, analysts plainly believe Scienture is more favorable than Hong Kong Pharma Digital Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scienture	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Scienture had 1 more articles in the media than Hong Kong Pharma Digital Technology. MarketBeat recorded 3 mentions for Scienture and 2 mentions for Hong Kong Pharma Digital Technology. Hong Kong Pharma Digital Technology's average media sentiment score of 1.31 beat Scienture's score of 0.30 indicating that Hong Kong Pharma Digital Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Scienture	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hong Kong Pharma Digital Technology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Scienture has a beta of 3.28, suggesting that its stock price is 228% more volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.49, suggesting that its stock price is 149% more volatile than the broader market.

Summary

Scienture beats Hong Kong Pharma Digital Technology on 8 of the 13 factors compared between the two stocks.

How does Hong Kong Pharma Digital Technology compare to Ten-League International?

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) and Ten-League International (NASDAQ:TLIH) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Company	Net Margins	Return on Equity	Return on Assets
Hong Kong Pharma Digital Technology	N/A	N/A	N/A
Ten-League International	N/A	N/A	N/A

In the previous week, Hong Kong Pharma Digital Technology and Hong Kong Pharma Digital Technology both had 2 articles in the media. Ten-League International's average media sentiment score of 1.43 beat Hong Kong Pharma Digital Technology's score of 1.31 indicating that Ten-League International is being referred to more favorably in the news media.

Company	Overall Sentiment
Hong Kong Pharma Digital Technology	Positive
Ten-League International	Positive

Ten-League International has higher revenue and earnings than Hong Kong Pharma Digital Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hong Kong Pharma Digital Technology	$20.31M	0.20	-$30K	N/A	N/A
Ten-League International	$59.24M	0.28	$4.34M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Ten-League International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Ten-League International beats Hong Kong Pharma Digital Technology on 4 of the 4 factors compared between the two stocks.

Get Hong Kong Pharma Digital Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HKPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HKPD vs. The Competition

Export

Metric	Hong Kong Pharma Digital Technology	Wholesale – Drugs & Drug Proprietaries Industry	Retail Sector	NASDAQ Exchange
Market Cap	$3.64M	$3.64M	$26.36B	$12.26B
Dividend Yield	N/A	N/A	176.90%	9.79%
P/E Ratio	N/A	N/A	22.21	23.64
Price / Sales	0.20	0.20	2.15	89.45
Price / Cash	N/A	N/A	17.37	59.64
Price / Book	0.81	0.81	6.35	6.07
Net Income	-$30K	-$30K	$954.23M	$331.99M
7 Day Performance	-3.89%	-3.89%	-2.15%	-0.63%
1 Month Performance	-1.56%	-1.56%	-1.59%	-2.00%
1 Year Performance	-72.33%	-72.33%	-5.05%	13.62%

Hong Kong Pharma Digital Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HKPD Hong Kong Pharma Digital Technology	0.6305 of 5 stars	$0.37 +10.3%	N/A	-71.7%	$3.64M	$20.31M	N/A	19	Positive News Gap Down
COSM Cosmos Health	1.5892 of 5 stars	$0.29 flat	N/A	-66.1%	$18.17M	$65.27M	N/A	100	Positive News
NHTC Natural Health Trends	0.853 of 5 stars	$1.90 flat	N/A	-60.7%	$16.30M	$39.78M	N/A	140	Upcoming Earnings Short Interest Increase
EPSM Epsium Enterprise	0.4008 of 5 stars	$1.20 flat	N/A	-90.6%	$16.13M	$5.12M	N/A	13
SCNX Scienture	2.2297 of 5 stars	$0.37 flat	$1.50 +305.3%	-81.8%	$15.04M	$430K	N/A	N/A	Short Interest Increase Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HKPD) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. COSM, NHTC, EPSM, SCNX, and TLIH

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Summary

How does Hong Kong Pharma Digital Technology compare to Natural Health Trends?

Summary

How does Hong Kong Pharma Digital Technology compare to Epsium Enterprise?

Summary

How does Hong Kong Pharma Digital Technology compare to Scienture?

Summary

How does Hong Kong Pharma Digital Technology compare to Ten-League International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hong Kong Pharma Digital Technology (HKPD) Competitors

HKPD vs. COSM, NHTC, EPSM, SCNX, and TLIH

How does Hong Kong Pharma Digital Technology compare to Cosmos Health?

Does the media refer more to HKPD or COSM?

Which has more risk & volatility, HKPD or COSM?

Is HKPD or COSM more profitable?

Which has better valuation and earnings, HKPD or COSM?

Do insiders & institutionals believe in HKPD or COSM?

Do analysts prefer HKPD or COSM?

Summary

How does Hong Kong Pharma Digital Technology compare to Natural Health Trends?

Which has better valuation and earnings, HKPD or NHTC?

Which has more risk & volatility, HKPD or NHTC?

Does the media refer more to HKPD or NHTC?

Do analysts rate HKPD or NHTC?

Is HKPD or NHTC more profitable?

Do institutionals and insiders have more ownership in HKPD or NHTC?

Summary

How does Hong Kong Pharma Digital Technology compare to Epsium Enterprise?

Do analysts recommend HKPD or EPSM?

Is HKPD or EPSM more profitable?

Does the media prefer HKPD or EPSM?

Which has preferable earnings and valuation, HKPD or EPSM?

Which has more risk and volatility, HKPD or EPSM?

Summary

How does Hong Kong Pharma Digital Technology compare to Scienture?

Which has stronger earnings and valuation, SCNX or HKPD?

Do institutionals & insiders believe in SCNX or HKPD?

Is SCNX or HKPD more profitable?

Do analysts prefer SCNX or HKPD?

Does the media refer more to SCNX or HKPD?

Which has more volatility & risk, SCNX or HKPD?

Summary

How does Hong Kong Pharma Digital Technology compare to Ten-League International?

Is HKPD or TLIH more profitable?

Does the media refer more to HKPD or TLIH?

Which has better valuation and earnings, HKPD or TLIH?

Do analysts recommend HKPD or TLIH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HKPD vs. The Competition

Hong Kong Pharma Digital Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools